Healthcare is undergoing a structural shift, one that challenges not only how innovation is delivered, but how value itself is created. For decades, the healthcare industry largely operated within a product-centric model. Imaging systems, monitoring devices, software platforms, diagnostics, and pharmaceuticals were developed, sold, and deployed as discrete innovations, each designed to solve a specific problem.
That approach drove enormous advances in medicine. But today’s healthcare challenges rarely exist in isolation. Now, healthcare organizations are being asked to deliver more coordinated, personalized care at a time when resources are increasingly constrained. The World Health Organization projects a global shortage of 11 million health workers by 2030, creating additional pressure on health systems to improve efficiency while managing increasingly complex patient journeys that span multiple providers, specialties, and care settings.
Phil RackliffeGE HealthCare
Episodes of care
The challenge is that many healthcare systems and business models were designed around episodes of care rather than continuous journeys. Technologies, workflows, and operating structures evolved to optimize individual moments: a scan, a diagnosis, a procedure, a treatment decision.
But patients do not experience healthcare as a series of disconnected interactions. They experience it as one continuous journey, often navigating multiple providers, settings, and handoffs along the way. As care becomes more longitudinal and interconnected, healthcare organizations are increasingly being asked to rethink systems built for a different era.
This shift is driving a move from products to pathways: an integrated model where technologies, data, and clinical insights work together across the continuum of care. Because increasingly, the challenge is not innovation itself. It is orchestration.
Oncology and cardiology
Nowhere is this more evident than in high-burden disease areas such as oncology and cardiology, where patients often move through highly complex care journeys involving multiple specialists, diagnostic tools, and treatment decisions. Fragmented workflows can delay diagnosis, create inefficiencies, complicate clinical decision-making, and ultimately impact outcomes. A pathway-based approach is designed to create greater continuity across that experience.
In a pathway-centric model, value is no longer defined solely by the performance of a single device, application, or intervention. Instead, it is measured by how effectively technologies, insights, and workflows work together to improve patient outcomes and support timely, informed decisions across care teams.
Consider a patient undergoing cancer evaluation. That journey may involve imaging studies, pathology findings, laboratory diagnostics, multidisciplinary consultation, therapy planning, treatment monitoring, and longitudinal follow-up. Historically, many of these interactions occurred within separate systems requiring manual coordination and interpretation. The result is often an experience that depends as much on navigation as innovation.
A pathway-driven model
A pathway-driven model seeks to create greater continuity by connecting those components, helping clinicians move more seamlessly from detection to diagnosis to therapy planning and beyond. Importantly, this represents more than a workflow redesign. It may also require a new way of defining success.
Historically, healthcare innovation often focused on measuring the performance of individual interventions: image quality, device performance, procedural efficiency, or software functionality. While those metrics remain important, pathway-based models introduce a broader question: how effectively do technologies work together to improve outcomes across the entire care experience?
Increasingly, the measure of success may shift from optimizing individual moments to improving continuity across them. For providers, this could mean moving beyond procurement strategies focused on point solutions toward broader enterprise ecosystems. For industry, it demands greater emphasis on interoperability, cloud-enabled infrastructure, and integrated offerings designed around clinical workflows rather than individual products. Data will play a central role in this evolution.
Aggregating, analyzing information
Pathway-based care depends on the ability to aggregate and analyze information across modalities and over time, including imaging, clinical records, diagnostics, and increasingly real-world evidence. But information alone is not enough. The future advantage may belong to organizations that can turn connected data into connected decisions.
When integrated effectively, these insights may help support earlier diagnosis, more personalized care pathways, improved operational efficiency, and ongoing patient monitoring. Ultimately, the shift from products to pathways reflects something larger than technology evolution. It reflects a broader transition toward precision care models designed around people rather than products.
For years, healthcare organizations focused on improving individual points along the journey. Now, the next chapter is about redesigning the journey itself.
Phil Rackliffe is president and CEO of Advanced Imaging Solutions (AIS) at GE HealthCare. Phil has nearly three decades of global healthcare experience across both private and public companies, including Baxter International Inc., Boston Scientific Corporation, and Pfizer Inc.
The comments and observations expressed are those of the author and do not necessarily reflect the opinions of AuntMinnie.com.
